Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 243

1.

FIXED DOSE COMBINATIONS WITH SELECTIVE BETA-BLOCKERS: QUANTITATIVE DETERMINATION IN BIOLOGICAL FLUIDS.

Mahu ŞC, Hăncianu M, Agoroaei L, Grigoriu IC, Strugaru AM, Butnaru E.

Rev Med Chir Soc Med Nat Iasi. 2015 Apr-Jun;119(2):585-91.

PMID:
26204671
3.

Economic benefits associated with beta blocker persistence in the treatment of hypertension: a retrospective database analysis.

Chen S, Swallow E, Li N, Faust E, Kelley C, Xie J, Wu E.

Curr Med Res Opin. 2015 Apr;31(4):615-22. doi: 10.1185/03007995.2015.1013624. Epub 2015 Feb 17.

PMID:
25651483
4.

Potential Drug - Drug Interactions among Medications Prescribed to Hypertensive Patients.

Kothari N, Ganguly B.

J Clin Diagn Res. 2014 Nov;8(11):HC01-4. doi: 10.7860/JCDR/2014/10032.5091. Epub 2014 Nov 20.

5.

β-blockers: a review of their pharmacological and physiological diversity in hypertension.

Ripley TL, Saseen JJ.

Ann Pharmacother. 2014 Jun;48(6):723-33. doi: 10.1177/1060028013519591. Epub 2014 Mar 31. Review.

PMID:
24687542
6.

Photo-Fenton decomposition of β-blockers atenolol and metoprolol; study and optimization of system parameters and identification of intermediates.

Veloutsou S, Bizani E, Fytianos K.

Chemosphere. 2014 Jul;107:180-6. doi: 10.1016/j.chemosphere.2013.12.031. Epub 2014 Feb 28.

PMID:
24589299
7.

Treatment of hypertension in peripheral arterial disease.

Lane DA, Lip GY.

Cochrane Database Syst Rev. 2013 Dec 4;12:CD003075. doi: 10.1002/14651858.CD003075.pub3. Review.

PMID:
24307487
8.

Pharmaco-nutrient interactions - a systematic review of zinc and antihypertensive therapy.

Braun LA, Rosenfeldt F.

Int J Clin Pract. 2013 Aug;67(8):717-25. doi: 10.1111/ijcp.12040. Epub 2012 Dec 26. Review.

PMID:
23279674
9.

Cardioselective beta-blocker treatment of hypertension in patients with asthma: when do benefits outweigh risks?

Self TH, Wallace JL, Soberman JE.

J Asthma. 2012 Nov;49(9):947-51. doi: 10.3109/02770903.2012.719252. Epub 2012 Sep 13.

PMID:
22974249
10.

HPLC method for determination of atenolol in human plasma and application to a pharmacokinetic study in Turkey.

Yilmaz B, Arslan S, Asci A.

J Chromatogr Sci. 2012 Nov-Dec;50(10):914-9. doi: 10.1093/chromsci/bms090. Epub 2012 Jun 19.

11.

Use of carvedilol in hypertension: an update.

Leonetti G, Egan CG.

Vasc Health Risk Manag. 2012;8:307-22. doi: 10.2147/VHRM.S31578. Epub 2012 May 18. Review.

12.

Vasodilating versus first-generation β-blockers for cardiovascular protection.

Fares H, Lavie CJ, Ventura HO.

Postgrad Med. 2012 Mar;124(2):7-15. doi: 10.3810/pgm.2012.03.2532. Review.

PMID:
22437211
13.

Persistence with nebivolol in the treatment of hypertension: a retrospective claims analysis.

Signorovitch JE, Samuelson TM, Ramakrishnan K, Marynchenko M, Wu EQ, Blum SI, Ramasamy A, Chen S.

Curr Med Res Opin. 2012 Apr;28(4):591-9. doi: 10.1185/03007995.2012.668495. Epub 2012 Mar 16.

PMID:
22352883
14.

Carvedilol: a third-generation β-blocker should be a first-choice β-blocker.

DiNicolantonio JJ, Hackam DG.

Expert Rev Cardiovasc Ther. 2012 Jan;10(1):13-25. doi: 10.1586/erc.11.166. Review.

PMID:
22149523
15.
16.

β-blockers as endocrine disruptors: the potential effects of human β-blockers on aquatic organisms.

Massarsky A, Trudeau VL, Moon TW.

J Exp Zool A Ecol Genet Physiol. 2011 Jun 1;315(5):251-65. doi: 10.1002/jez.672. Epub 2011 Mar 1. Review.

17.

Risk of new-onset diabetes mellitus associated with beta-blocker treatment for hypertension.

Fonseca V, Sharma PP, Shah M, Deedwania P.

Curr Med Res Opin. 2011 Apr;27(4):799-807. doi: 10.1185/03007995.2011.555477. Epub 2011 Feb 10.

PMID:
21306286
18.

Effect of atenolol vs metoprolol succinate on vascular function in patients with hypertension.

Heffernan KS, Suryadevara R, Patvardhan EA, Mooney P, Karas RH, Kuvin JT.

Clin Cardiol. 2011 Jan;34(1):39-44. doi: 10.1002/clc.20841.

19.
20.
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk